Therefore, to understand the molecular basis of the combinatorial administration of probiotics and celecoxib in experimental CRC the present study was designed to assess the effect of tumor modulation with respect to apoptosis vis-à-vis expression of p53 and K-ras gene. Here, KRAS is linked to colorectal carcinoma.